How patient experience and real-world evidence reshape hematology advances in rare disease and blood cancers, beyond clinical end points. This commentary will appear in the May issue of Evidence-Based Oncology.
Jeff Schaffnit, MBA
Advertisement
Articles by Jeff Schaffnit, MBA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Lipoprotein(a): An FAQ on Awareness, Risk, and Screening Gaps
2
$20 Billion National Strategy Aims to Close the Women's Health Gap
3
Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women
4
5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care
5